Dhadha Ajay Kumar 4
4 · Raphael Pharmaceutical Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Dhadha Ajay Kumar
Director
Transactions
- Award
Common Stock
2025-03-05+350,000→ 351,667 total - Award
Warrant to purchase Common Stock
2025-03-05+250,000→ 250,000 totalExercise: $1.00Exp: 2026-12-31→ Common Stock (250,000 underlying)
Holdings
- 403,153(indirect: By Shanti Gems International Investments Ltd.)
Common Stock
Footnotes (1)
- [F1]350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.